Member Info for Midas3316

At the moment there isn’t any holding more than 3%. Never mind 51%.

Lol. Pmsl. No please explain. Pmsl. Seriously. I would stick to scratch cards. Yes people can secretly buy 10,20, 30% of a company without anyone knowing. Lol.

Regardless of who or which method of investment, you have to report holdings of 3% as an individual or 3% of a total holding of any number of individuals. You should get to know the rules before you play the game.

Pmsl. Check it out. Just like Invesco who is currently the largest holder with around 3%. That is actually owned by hundreds of unit holders.

They would still have to release a TR1 if their entire holding for their clients is above 3%.

His account is still there

Well. Whatever happens I hope it’s a good deal for you. I’m very curious to the outcome. I’ve worked in clinical trials for many years and have never seen a drug through as many trials as this. I’m busy buying shares in the covid trials we are conducting. Lol.

Yes. It is Dollars. So around £9m total debt. Give or take.

Sept. It was around £11m.

I think that’s what they owe to Hercules.

From memory I think Motif have debts of around £10m. £7m owed to Hercules. Do you really believe it’s worth more than £10m ??? They haven’t been inundated with offers.

Option A. Is that with Lamellar. If it is Lamellar then B would like you say be the better choice. What if another company buys Iclaprim ???

The link as in working on drugs together.

Could be if it’s to get its hands on Iclaprim. Hercules would have the deciding factor. That way they wouldn’t have to buy Iclaprim they could just give Hercules even more of the combined company. Tamarack haven’t had much luck in selling Iclaprim. What if there was an RNS to say Iclaprim has been sold for £7m ???

Both Motif and Lamellar have the CF link, that most people are picking up on. The only way I could see a RTO being better for Lamellar rather than just buying Iclaprim rights from Tamarack. Is that Tamarack might be looking for £10m or so to clear Motifs debts and they might find it cheaper to do a RTO deal with Motif plc and Motif ltd. followed by fund raising. If that’s the case then they will need 10’s of Millions and another couple of years to see if it’s 4th time lucky for Iclaprim. After all these years and companies I still find it hard to believe people still willing to put more money into Iclaprim.

Yes. Not impossible . Lamellar is working on the way drugs are administered. They did have a link with Motif a while back. But as far as I know they closed that when Motif ceased. I’m curious to see how this ends up. I would think a RTO will go ahead but not sure of Iclaprim etc.

Research deeper. Use the other names Iclaprim has been known by in over 20 years.

Dingle. That wasn’t this time around is was the time before. It’s had 3 / 4 if you count the trail unpublished stage 3

The FDA advisory committee said that the drug "should not be developed further" based on the results presented. A parallel application for marketing approval to the EMA was withdrawn in 2009

Good work Kettle. Getting it blue. So do you think anyone would want Iclaprim after all this ??? Tens of millions and years required on the hope that its 4th time lucky

Yes. That’s better. Don’t want to upset anyone. Let’s just say it didn’t pass stage 3. But instead was given a U grade.